Jay M. Bakas
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jay M. Bakas has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
Marie Josee E. van Rijn
Department of Vascular Surgery, Erasmus University Medical Center, Rotterdam, the Netherlands
8 shared publicationsCatherine van Montfrans
Department of Dermatology, Erasmus University Medical Center, Rotterdam, the Netherlands
5 shared publicationsAdriaan Moelker
Department of Radiology and Nuclear Medicine, Erasmus Medical Center, Rotterdam, the Netherlands
4 shared publicationsRenate R. van Den Bos
Department of Dermatology, Erasmus University Medical Center, Rotterdam, the Netherlands
3 shared publicationsWendy S.J. Malskat
Department of Dermatology, Erasmus University Medical Center, Rotterdam, the Netherlands
3 shared publications- Hence J. M. Verhagen
Department of Vascular Surgery, Erasmus University Medical Centre, Rotterdam, The Netherlands
2 shared publications
Latest Publications
- Open Access
- 30 January 2026
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 72 (1) , 187-195
Anticoagulation Management and Recurrent Thrombosis after Venous Stenting for Deep Vein Thrombosis and Post-thrombotic Syndrome
- 30 January 2026
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 72 (1) , 187-195
Open AccessAnticoagulation Management and Recurrent Thrombosis after Venous Stenting for Deep Vein Thrombosis and Post-thrombotic Syndrome
- Open Access
- 9 December 2024
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 36 (3) , 446-455
Venous Stents Placed for Postthrombotic Syndrome: The Role of Inflow Disease on Patency
- 9 December 2024
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 36 (3) , 446-455
Open AccessVenous Stents Placed for Postthrombotic Syndrome: The Role of Inflow Disease on Patency
- 19 March 2024
- Vol. 168
[Spontaneous retroperitoneal hematoma].
Spontaneous retroperitoneal hematoma refers to bleeding of the retroperitoneal space without prior trauma or iatrogenic injury. Its diagnosis is often delayed due to a nonspecific clinical presentation. This case-series presents three patients with spontaneous retroperitoneal bleeding. Patient A presented with a spontaneous bleeding around the right iliopsoas muscle due to antiplatelet medication and was managed conservatively. Patient B had a spontaneous arterial bleeding near the right kidney, subsequently determined to be associated with a pheochromocytoma. Endovascular treatment successfully stopped the bleeding. The pheochromocytoma was resected during follow-up. Patient C had a spontaneous rupture of the left iliac vein with a concomitant deep vein thrombosis. She underwent emergent laparotomy, but unfortunately did not survive. This case-series emphasize the diverse presentation, varied causes, and different treatment strategies for spontaneous retroperitoneal hematoma. Timely diagnosis is hard, but crucial to enable an individualized treatment.
- 19 March 2024
- Vol. 168
[Spontaneous retroperitoneal hematoma].
Spontaneous retroperitoneal hematoma refers to bleeding of the retroperitoneal space without prior trauma or iatrogenic injury. Its diagnosis is often delayed due to a nonspecific clinical presentation. This case-series presents three patients with spontaneous retroperitoneal bleeding. Patient A presented with a spontaneous bleeding around the right iliopsoas muscle due to antiplatelet medication and was managed conservatively. Patient B had a spontaneous arterial bleeding near the right kidney, subsequently determined to be associated with a pheochromocytoma. Endovascular treatment successfully stopped the bleeding. The pheochromocytoma was resected during follow-up. Patient C had a spontaneous rupture of the left iliac vein with a concomitant deep vein thrombosis. She underwent emergent laparotomy, but unfortunately did not survive. This case-series emphasize the diverse presentation, varied causes, and different treatment strategies for spontaneous retroperitoneal hematoma. Timely diagnosis is hard, but crucial to enable an individualized treatment.
- Open Access
- 4 January 2024
- Published by Elsevier in EJVES Vascular Forum
- Vol. 61, 44-49
Quality of Life After Early Clot Removal for Acute Iliofemoral Deep Vein Thrombosis
- 4 January 2024
- Published by Elsevier in EJVES Vascular Forum
- Vol. 61, 44-49
Open AccessQuality of Life After Early Clot Removal for Acute Iliofemoral Deep Vein Thrombosis
- Open Access
- 29 December 2023
- Published by SAGE Publications in Vascular and Endovascular Surgery
- Vol. 58 (5) , 469-476
Quality of Life after Venous Stenting for Post-thrombotic Syndrome and the Effect of Inflow Disease
Objective: Patients with PTS experience an impaired quality of life (QoL). We aimed to study QoL in patients stented for post thrombotic syndrome (PTS) and analyze the influence of different parameters. Methods: Patients stented for PTS after iliofemoral deep vein thrombosis were asked to complete the Chronic Venous Disease Quality of Life Questionnaire (CIVIQ-20) and the Short Form Health Survey (SF-36) in this cross-sectional study. All other data were collected retrospectively. Primary endpoints were median CIVIQ-20 and physical (PCS) and mental (MCS) component summary SF-36 scores. The influence of age, sex, and years between the procedure and completion of questionnaire were investigated using a multivariate linear regression model. Wilcoxon signed rank test compared the PCS and MCS with the normative. Effects of inflow from the deep femoral vein (DFV) and/or the femoral vein (FV) on QoL was analyzed in patients with patent stents. Results: The response rate was 70.3% (n = 45/64). Time period (median) from stenting to questionnaire completion was 6.6 years (IQR: 8.0). Most stents were placed unilateral left-sided (73.3%). For patients with patent stents (n = 42) median CIVIQ-20 was 35.5 (IQR: 17.3), higher than the minimum of 20.0 ( P < .001). Median PCS of 44.7 (IQR: 14.2) was lower ( P < .001), and MCS of 55.9 (IQR: 7.1) higher ( P = .001) than the normative (50.0). Time since stenting and sex were not associated with QoL. Age was a significant predictor [standardized coefficient ß = .36, P = .04] for QoL using the CIVIQ-20, but not for the SF-36. Inflow disease did not impact QoL, but patients with occluded stents (n = 3) had poor functioning levels. Conclusion: Quality of life is impaired after venous stenting for PTS, particularly physical functioning, among patients with an open stent, but was similar between patients with good and impaired inflow. Patients with a permanent stent occlusion had the lowest QoL.
- 29 December 2023
- Published by SAGE Publications in Vascular and Endovascular Surgery
- Vol. 58 (5) , 469-476
Open AccessQuality of Life after Venous Stenting for Post-thrombotic Syndrome and the Effect of Inflow Disease
Objective: Patients with PTS experience an impaired quality of life (QoL). We aimed to study QoL in patients stented for post thrombotic syndrome (PTS) and analyze the influence of different parameters. Methods: Patients stented for PTS after iliofemoral deep vein thrombosis were asked to complete the Chronic Venous Disease Quality of Life Questionnaire (CIVIQ-20) and the Short Form Health Survey (SF-36) in this cross-sectional study. All other data were collected retrospectively. Primary endpoints were median CIVIQ-20 and physical (PCS) and mental (MCS) component summary SF-36 scores. The influence of age, sex, and years between the procedure and completion of questionnaire were investigated using a multivariate linear regression model. Wilcoxon signed rank test compared the PCS and MCS with the normative. Effects of inflow from the deep femoral vein (DFV) and/or the femoral vein (FV) on QoL was analyzed in patients with patent stents. Results: The response rate was 70.3% (n = 45/64). Time period (median) from stenting to questionnaire completion was 6.6 years (IQR: 8.0). Most stents were placed unilateral left-sided (73.3%). For patients with patent stents (n = 42) median CIVIQ-20 was 35.5 (IQR: 17.3), higher than the minimum of 20.0 ( P < .001). Median PCS of 44.7 (IQR: 14.2) was lower ( P < .001), and MCS of 55.9 (IQR: 7.1) higher ( P = .001) than the normative (50.0). Time since stenting and sex were not associated with QoL. Age was a significant predictor [standardized coefficient ß = .36, P = .04] for QoL using the CIVIQ-20, but not for the SF-36. Inflow disease did not impact QoL, but patients with occluded stents (n = 3) had poor functioning levels. Conclusion: Quality of life is impaired after venous stenting for PTS, particularly physical functioning, among patients with an open stent, but was similar between patients with good and impaired inflow. Patients with a permanent stent occlusion had the lowest QoL.
- 9 October 2023
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 67 (3) , 523
Deep Venous Intervention: The Need For Further Investigation
- 9 October 2023
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 67 (3) , 523
Deep Venous Intervention: The Need For Further Investigation
- 23 August 2023
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 66 (5) , 705-706
Non-Random Prescription of Anticoagulation Causes Confounding by Indication
- 23 August 2023
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 66 (5) , 705-706
Non-Random Prescription of Anticoagulation Causes Confounding by Indication
- Open Access
- 5 July 2023
- Published by SAGE Publications in Vascular and Endovascular Surgery
- Vol. 58 (1) , 100-104
Exercise Intolerance That Resolved After venous Stenting of the Inferior Vena Cava
Venous stenting could alleviate exercise intolerance associated with chronic inferior vena cava (IVC) obstruction. We describe a 36-year-old male patient with an unknown IVC-obstruction. The obstruction was discovered after a bi-iliac deep vein thrombosis (DVT). The thrombus was resolved using thrombolysis. In the chronic phase, the patient developed exercise intolerance without any leg-specific symptoms or signs. Venous stenting was performed to open the IVC-obstruction, 1 year after the acute DVT. His physical condition improved, but cardiac magnetic resonance imaging at rest did not reveal hemodynamical changes after stenting. The Short Form Health Survey (SF-36) physical and mental component summaries were increased from 40.3 to 46.1 and 42.2 to 53.7, respectively. In patients with iliocaval obstruction, improved venous flow without changes in resting hemodynamics can enhance exercise intolerance and quality of life, even in the absence of leg symptoms. Diagnostic tools performed only at rest may miss abnormalities.
- 5 July 2023
- Published by SAGE Publications in Vascular and Endovascular Surgery
- Vol. 58 (1) , 100-104
Open AccessExercise Intolerance That Resolved After venous Stenting of the Inferior Vena Cava
Venous stenting could alleviate exercise intolerance associated with chronic inferior vena cava (IVC) obstruction. We describe a 36-year-old male patient with an unknown IVC-obstruction. The obstruction was discovered after a bi-iliac deep vein thrombosis (DVT). The thrombus was resolved using thrombolysis. In the chronic phase, the patient developed exercise intolerance without any leg-specific symptoms or signs. Venous stenting was performed to open the IVC-obstruction, 1 year after the acute DVT. His physical condition improved, but cardiac magnetic resonance imaging at rest did not reveal hemodynamical changes after stenting. The Short Form Health Survey (SF-36) physical and mental component summaries were increased from 40.3 to 46.1 and 42.2 to 53.7, respectively. In patients with iliocaval obstruction, improved venous flow without changes in resting hemodynamics can enhance exercise intolerance and quality of life, even in the absence of leg symptoms. Diagnostic tools performed only at rest may miss abnormalities.
- Open Access
- 28 June 2023
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 66 (3) , 389-396
Long Term Follow Up, Causes for Re-intervention, and Consequences for Surveillance After Stenting for Proximal Deep Vein Obstruction
- 28 June 2023
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 66 (3) , 389-396
Open AccessLong Term Follow Up, Causes for Re-intervention, and Consequences for Surveillance After Stenting for Proximal Deep Vein Obstruction
- Open Access
- 7 June 2023
- Published by SAGE Publications in Journal of Endovascular Therapy
- Vol. 32 (2) , 524-528
A Case of Complete Resolution of Cauda Equina Syndrome Caused by Extensive Iliocaval Thrombosis: The Role of Thrombolysis and Venous Stents
Purpose: The cauda equina syndrome (CES) is a rare condition affecting less than 1 in 100,000 patients annually. Diagnosing CES is challenging because of its rare incidence, potentially subtle presentation, and various underlying etiologies. Vascular causes, such as inferior vena cava (IVC) thrombosis, are uncommon but should be considered, since timely recognition and treatment of deep vein thrombosis (DVT) as a cause of CES can avoid irreversible neurological damage. Case report: A 30-year-old male presented with partial CES caused by nerve root compression due to venous congestion from an extensive iliocaval DVT. He completely recovered after thrombolysis and stenting of the IVC. His iliocaval tract remained patent until the last date of follow-up at 1 year without signs of post-thrombotic syndrome. Broad molecular, infectious, and hematological laboratory tests did not reveal any underlying disease for the thrombotic event, particularly no hereditary or acquired thrombophilia. Conclusion: Timely recognition of venous thrombosis as a cause of CES is essential. This is the first case report of CES caused by an extensive iliocaval DVT successfully treated with thrombolysis and venous stenting with good resolution of DVT and CES. Clinical Impact: This case-report describes a patient with cauda equina syndrome resulting from an extensive iliocaval deep vein thrombosis due to an underlying stenosis of the inferior vena cava. Thrombolysis and venous stenting succesfully restored venous patency and thereby relieved symptoms and signs of cauda equina syndrome, in addition to (long-term) therapeutic dose anticoagulation. It is important to timely recognize deep vein thrombosis as a cause of cauda equina syndrome and to consider endovenous treatment in a specialized center.
- 7 June 2023
- Published by SAGE Publications in Journal of Endovascular Therapy
- Vol. 32 (2) , 524-528
Open AccessA Case of Complete Resolution of Cauda Equina Syndrome Caused by Extensive Iliocaval Thrombosis: The Role of Thrombolysis and Venous Stents
Purpose: The cauda equina syndrome (CES) is a rare condition affecting less than 1 in 100,000 patients annually. Diagnosing CES is challenging because of its rare incidence, potentially subtle presentation, and various underlying etiologies. Vascular causes, such as inferior vena cava (IVC) thrombosis, are uncommon but should be considered, since timely recognition and treatment of deep vein thrombosis (DVT) as a cause of CES can avoid irreversible neurological damage. Case report: A 30-year-old male presented with partial CES caused by nerve root compression due to venous congestion from an extensive iliocaval DVT. He completely recovered after thrombolysis and stenting of the IVC. His iliocaval tract remained patent until the last date of follow-up at 1 year without signs of post-thrombotic syndrome. Broad molecular, infectious, and hematological laboratory tests did not reveal any underlying disease for the thrombotic event, particularly no hereditary or acquired thrombophilia. Conclusion: Timely recognition of venous thrombosis as a cause of CES is essential. This is the first case report of CES caused by an extensive iliocaval DVT successfully treated with thrombolysis and venous stenting with good resolution of DVT and CES. Clinical Impact: This case-report describes a patient with cauda equina syndrome resulting from an extensive iliocaval deep vein thrombosis due to an underlying stenosis of the inferior vena cava. Thrombolysis and venous stenting succesfully restored venous patency and thereby relieved symptoms and signs of cauda equina syndrome, in addition to (long-term) therapeutic dose anticoagulation. It is important to timely recognize deep vein thrombosis as a cause of cauda equina syndrome and to consider endovenous treatment in a specialized center.